Kalil G. Abdullah, M.D. is an Instructor in the Department of Neurosurgery at the Perelman School of Medicine of the University of Pennsylvania. Dr. Abdullah’s research focus is on the outcomes of patients undergoing neurosurgery for brain tumors, particularly glioblastoma, the most common primary malignant brain tumor. He is the co-founder and director of the Penn Glioma Project, which was established in 2016 with the aim of creating a comprehensive clinical, economic, and genomic outcomes database for patients with glioblastoma. To-date, this project has analysed over 800 patients and 100,000 clinical and economic data points, making it one of the most comprehensive databases of its kind. He is the principal investigator for a longitudinal project to determine an alternative quality of life metric to better stratify and report quality of life outcomes for patients with glioblastoma.
Dr. Abdullah received his medical degree from the Cleveland Clinic Lerner College of Medicine, where was a Howard Hughes Medical Institute Scholar at the National Institutes of Health. While at Cleveland Clinic, he co-founded the Cleveland Clinic Spine Outcomes Research Laboratory, focusing on the evaluation of quality of life outcomes and cost-utility of spinal and neuro-oncological surgery. He completed a fellowship in open and endoscopic neurosurgical oncology at the Wellington Hospital in Wellington, New Zealand and a research-based post-doctoral fellowship in the Department of Bioengineering at the University of Pennsylvania. He is the co-editor of the textbook “Glioblastoma”, and his research on cost and quality outcomes have been published in Neurosurgery, Spine, The Journal of Neurosurgery, and PLOS One. Dr. Abdullah additionally runs a translational science laboratory at the Perelman School of Medicine investigating the intracranial use of advanced biopolymers after resection of malignant brain tumors.